TVARDI THERAPEUTICS INC (TVRD) Stock Earnings & Estimates
USA - NASDAQ:TVRD - US1407553072 - Common Stock
36.32 USD
-0.49 (-1.33%)
36.32 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.9M 82.17% | 20.968M -49.96% | 7.137M -65.96% | 530.4K -92.57% | -100.00% | N/A | N/A | ||
| EBITDA YoY % growth | -87.25M 1.80% | -121.236M -38.95% | -52.626M 56.59% | -66.289M -25.96% | -64.714M 2.38% | -57.964M 10.43% | N/A | N/A | |
| EBIT YoY % growth | -87.5M 1.80% | -121.495M -38.85% | -52.818M 56.53% | -32.533M 38.41% | -49.877M -53.31% | -76.533M -53.44% | N/A | N/A | |
| Operating Margin | -208.83% | -579.43% | -740.06% | -6,133.63% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -57.24 8.09% | -78.48 -37.11% | N/A 98.33% | -2.82 -115.07% | -3.91 -38.92% | -5.68 -45.27% | -7.06 -24.18% | -8.81 -24.94% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.02 87.70% | -0.84 -335.34% | -0.91 71.65% | -1.04 -3.53% | -1.08 -6.15% | -1.20 -42.36% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.369M -77.40% | -9.964M -79.62% | -10.856M -354.99% | -12.458M -18.80% | -13.853M -47.86% | -15.971M -60.29% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.00 92.49% | -0.58 | -0.42 | -71.45% |
| Q1 2025 Q2Q % growth | -3.22 84.03% | -0.36 | -2.86 | -801.96% |
| Q4 2024 Q2Q % growth | 99.09% | -0.19 | % | |
| Q3 2024 Q2Q % growth | -8.28 55.77% | -9.06 | 0.78 | 8.59% |
| Q2 2024 Q2Q % growth | -13.32 36.21% | -10.06 | -3.26 | -32.39% |
| Q1 2024 Q2Q % growth | -20.16 -14.29% | -14.61 | -5.55 | -37.94% |
| Q4 2023 Q2Q % growth | -21.24 -5.36% | -15.13 | -6.11 | -40.40% |
| Q3 2023 Q2Q % growth | -18.72 -20.93% | -19.09 | 0.37 | 1.96% |
| Q2 2023 Q2Q % growth | -20.88 -625.00% | -19.77 | -1.11 | -5.63% |
| Q1 2023 Q2Q % growth | -17.64 5.77% | -19.15 | 1.51 | 7.87% |
| Q4 2022 Q2Q % growth | -20.16 11.11% | -11.75 | -8.41 | -71.57% |
| Q3 2022 Q2Q % growth | -15.48 -2,050.00% | -15.37 | -0.11 | -0.72% |
| Q2 2022 Q2Q % growth | -2.88 86.89% | -9.30 | 6.42 | 69.04% |
| Q1 2022 Q2Q % growth | -18.72 -10.64% | -19.71 | 0.99 | 5.01% |
| Q4 2021 Q2Q % growth | -22.68 -139.62% | -18.94 | -3.74 | -19.77% |
| Q3 2021 Q2Q % growth | -0.72 94.29% | -14.53 | 13.81 | 95.04% |
| Q2 2021 Q2Q % growth | -21.96 -12.96% | -19.57 | -2.39 | -12.23% |
| Q1 2021 Q2Q % growth | -16.92 24.19% | -21.66 | 4.74 | 21.90% |
| Q4 2020 Q2Q % growth | 57.24 360.66% | 13.38 | 43.86 | 327.91% |
| Q3 2020 Q2Q % growth | -12.60 52.70% | -21.93 | 9.33 | 42.54% |
| Q2 2020 Q2Q % growth | -19.44 6.90% | -24.44 | 5.00 | 20.47% |
| Q1 2020 Q2Q % growth | -22.32 -10.71% | -22.72 | 0.40 | 1.76% |
| Q4 2019 Q2Q % growth | -21.96 | -24.19 | 2.23 | 9.24% |
| Q3 2019 Q2Q % growth | -26.64 | -21.26 | -5.38 | -25.32% |
| Q2 2019 Q2Q % growth | -20.88 | -22.55 | 1.67 | 7.39% |
| Q1 2019 Q2Q % growth | -20.16 | -21.13 | 0.97 | 4.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2025 Q2Q % growth | 2.569M 20.33% | 1.224M | 1.345M | 109.89% |
| Q4 2024 Q2Q % growth | 1.455M -51.56% | 1.628M | -173K | -10.63% |
| Q3 2024 Q2Q % growth | 2.556M -47.84% | 1.649M | 907K | 55.00% |
| Q2 2024 Q2Q % growth | 991K -85.64% | 1.197M | -206K | -17.21% |
| Q1 2024 Q2Q % growth | 2.135M -65.56% | 1.724M | 411K | 23.84% |
| Q4 2023 Q2Q % growth | 3.004M -8.97% | 9.61M | -6.606M | -68.74% |
| Q3 2023 Q2Q % growth | 4.9M -54.63% | 10.15M | -5.25M | -51.72% |
| Q2 2023 Q2Q % growth | 6.9M -70.00% | 6.693M | 207K | 3.09% |
| Q1 2023 Q2Q % growth | 6.2M 29.17% | 5.082M | 1.118M | 22.00% |
| Q4 2022 Q2Q % growth | 3.3M 312.50% | 16.576M | -13.276M | -80.09% |
| Q3 2022 Q2Q % growth | 10.8M -46.80% | 10.027M | 773K | 7.71% |
| Q2 2022 Q2Q % growth | 23M | 21.121M | 1.879M | 8.90% |
| Q1 2022 Q2Q % growth | 4.8M 152.63% | 3.227M | 1.573M | 48.74% |
| Q4 2021 Q2Q % growth | 800K -99.29% | 1.487M | -687K | -46.20% |
| Q3 2021 Q2Q % growth | 20.3M 118.28% | 11.431M | 8.869M | 77.59% |
| Q2 2021 Q2Q % growth | -100.00% | 2.645M | -2.645M | -100.00% |
| Q1 2021 Q2Q % growth | 1.9M -76.54% | 2.405M | -505K | -21.00% |
| Q4 2020 Q2Q % growth | 112.1M 2,391.11% | 49.601M | 62.499M | 126.00% |
| Q3 2020 Q2Q % growth | 9.3M 60.34% | 4.867M | 4.433M | 91.08% |
| Q2 2020 Q2Q % growth | 5.6M 7.69% | 5.158M | 442K | 8.57% |
| Q1 2020 Q2Q % growth | 8.1M 84.09% | 4.856M | 3.244M | 66.80% |
| Q4 2019 Q2Q % growth | 4.5M | 4.884M | -384K | -7.86% |
| Q3 2019 Q2Q % growth | 5.8M | 4.426M | 1.374M | 31.04% |
| Q2 2019 Q2Q % growth | 5.2M | 3.116M | 2.084M | 66.88% |
| Q1 2019 Q2Q % growth | 4.4M | 3.02M | 1.38M | 45.70% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.82% | -2.01% | -16.62% |
| Revenue | N/A | N/A | 0% | N/A |